You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Autologous Stem Cell Transplant

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, MDS, Transplant-Related Hematologic Malignancy Trial in Milano (Fludarabine, ARA-C, Treosulfan)

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Milano, Lombardia, Italy
    Ospedale San Raffaele
Jul 18, 2022

Multiple Myeloma Trial in United States (Pomalidomide, stem cell, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +9 more
Jan 23, 2023

Leukemia Trial (biological, drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • aldesleukin
  • +9 more
  • (no location specified)
Feb 17, 2022

Stem Cell Transplant Complications, Myeloma, Lymphoma Trial in Cleveland (physical therapy consult, Cognitive Assessment, Cancer

Recruiting
  • Stem Cell Transplant Complications
  • +3 more
  • physical therapy consult
  • +8 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
May 24, 2022

Multiple Myeloma Trial in Torino (Cyclophosphamide, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    Division of Hematology, Molinette Hospital
Apr 6, 2022

Diffuse Large B Cell Lymphoma Trial (Polatuzumab Vedotin)

Withdrawn
  • Diffuse Large B Cell Lymphoma
  • Polatuzumab Vedotin
  • (no location specified)
May 3, 2022

Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (Ixazomib Citrate, Lenalidomide,

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • Plasma Cell Myeloma
  • Ixazomib Citrate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 8, 2022

Multiple Myeloma Trial in Omaha (Iberdomide)

Recruiting
  • Multiple Myeloma
  • Omaha, Nebraska
    University of Nebraska Medical Center
Apr 27, 2022

Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (biological, drug, other)

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • Plasma Cell Myeloma
  • Elotuzumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

Relapse Multiple Myeloma, Multiple Myeloma Trial in Brno, Ostrava, Praha (OPD5)

Withdrawn
  • Relapse Multiple Myeloma
  • Multiple Myeloma
  • Brno, Czechia
  • +2 more
Nov 17, 2021

Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial (procedure, drug, biological, radiation, other)

Not yet recruiting
  • Recurrent Classic Hodgkin Lymphoma
  • Refractory Classic Hodgkin Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +13 more
  • (no location specified)
Feb 2, 2023

Newly Diagnosed Multiple Myeloma Trial in Germany (Isatuximab, Lenalidomide, Bortezomib)

Not yet recruiting
  • Newly Diagnosed Multiple Myeloma
  • Hamburg, Germany
  • +3 more
Dec 16, 2022

Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,

Recruiting
  • Autoimmune Disease
  • +18 more
  • Anti-Thymocyte Globulin
  • +9 more
  • Denver, Colorado
  • +2 more
Feb 1, 2023

Primary CNS Lymphoma, Secondary CNS Lymphoma, Relapsed Cancer Trial in Miami (drug, procedure, radiation)

Not yet recruiting
  • Primary Central Nervous System Lymphoma
  • +3 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Dec 23, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Laboratory Biomarker Analysis, Lenalidomide,

Completed
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Dec 1, 2021

Multiple Myeloma, Auto Stem Cell Transplant Trial in Hackensack (Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Auto Stem Cell Transplant
  • Hackensack, New Jersey
    John Theurer Cancer Center @ Hackensack University Medical Cente
Dec 23, 2022

Myeloma Multiple, Lymphoma Trial in Monterrey (Pegfilgrastim)

Recruiting
  • Myeloma Multiple
  • Lymphoma
  • Monterrey, Nuevo León, Mexico
    Hospital Universitario Dr. José Eleuterio González
Apr 18, 2022

T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)

Terminated
Has Results
  • T-cell Non-Hodgkin Lymphoma
  • Boston, Massachusetts
  • +1 more
Jan 26, 2023

Stem Cell Transplantation Trial in Cairo (conjunctival limbal autologous transplant)

Recruiting
  • Stem Cell Transplantation
  • conjunctival limbal autologous transplant
  • Cairo, Egypt
    Kasr Alainy
Aug 9, 2022

CIBMTR Research Database

Recruiting
  • Autologous Stem Cell Transplantation
  • +6 more
    • Minneapolis, Minnesota
    • +1 more
    Jan 20, 2023

    Mantle Cell Lymphoma Trial in Atlanta (Ixazomib, Rituximab)

    Active, not recruiting
    • Mantle Cell Lymphoma
    • Atlanta, Georgia
    • +1 more
    Oct 26, 2021

    B-cell Lymphoma, Burkitt Lymphoma, Diffuse Large B Cell Lymphoma Trial in Valhalla (Polatuzumab vedotin)

    Recruiting
    • B-cell Lymphoma
    • +8 more
    • Polatuzumab vedotin
    • Valhalla, New York
      New York Medical Center
    Oct 29, 2021

    Multiple Myeloma, Autologous Stem Cell Transplant Trial in Rochester (Distance Reiki, Sham distance Reiki)

    Recruiting
    • Multiple Myeloma
    • Autologous Stem Cell Transplant
    • Distance Reiki
    • Sham distance Reiki
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Apr 11, 2022

    Mantle Cell Lymphoma Trial in United States (Ofatumumab (This arm is closed), Ofatumumab + Bendamustine)

    Active, not recruiting
    • Mantle Cell Lymphoma
    • Ofatumumab (This arm is closed)
    • Ofatumumab + Bendamustine
    • Basking Ridge, New Jersey
    • +5 more
    Oct 1, 2021

    Multiple Myeloma Trial in Atlanta, Chicago (procedure, drug, other)

    Recruiting
    • Multiple Myeloma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +2 more
    • Atlanta, Georgia
    • +1 more
    Feb 25, 2022